Clinical trials are the most costly, time-consuming, and heavily regulated stages in drug development, often costing hundreds of millions of dollars and sometimes exceeding a billion dollars. Every month of delay cuts into the patent-protected window that determines a drug’s commercial viability, with companies losing tens of millions of dollars
En la era de la inteligencia artificial y el machine learning, el valor de los datos es incuestionable. Los modelos aprenden, predicen y toman decisiones a partir de los datos con los que son entrenados. Sin embargo, cuando los datos reales escasean o no pueden utilizarse por razones de privacidad,
AI and automation – often referred to as hyperautomation – are evolving rapidly with industry experts emphasizing their increasing ability to operate independently and make intelligent decisions. By combining powerful generative AI with business expertise, organizations can accelerate and streamline their processes like never before. I recently sat down with Mayank
There is no question that organizations worldwide are increasing their investment in AI. There is also little doubt that AI is starting to impact many different sectors. The health care and life sciences sectors are no exception, with many organizations investing in new technology. The real issue is how to
Dans le paysage technologique actuel, les données synthétiques, nouveau sous ensemble de l’IA générative, apportent de nouvelles pistes de réflexion pour la création des modèles d'intelligence artificielle. Contrairement aux données traditionnelles, pouvant être limitées par des contraintes de biais, de quantité, ou encore des contraintes de confidentialité et de conformité,
As in most other sectors, health care is changing at lightning speed. Access to data makes it possible to speed up clinical trials, develop more personalized medication, make quicker and better diagnoses, improve the quality of patient care and save lives. The pandemic has sped up digital transformation in every
Data is crucial for the development of artificial intelligence (AI) applications. However, the rapid availability of data is a challenge due to increasingly strict privacy regulations. A possible solution is to use synthetic data. Gartner predicts by 2024 that 60% of the data used to develop AI and analytics applications
